Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,580 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

for
Venous Thromboembolism, Metastatic Pancreatic Cancer,
Location: Ventura CA, Miami Lakes FL, Boston MA
Sponsor: Quercis Pharma AG

Sex: All

Age: 18+

Code: NCT06861088

Phase 3, Recruiting

Alleviant ALLAY-HF Study

for
Heart Failure
Location: Long Beach CA, Santa Barbara CA, San Diego CA,
Sponsor: Alleviant Medical, Inc.

Sex: All

Age: 40+

Code: NCT05685303

Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Beverly Hills CA, Los Angeles CA, Los Alamitos CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361510

Phase 3, Recruiting

Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment

for
HIV-1-infection
Location: Torrance CA, Fort Worth TX, Dallas TX, Kansas City MO,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07708727

Phase 2, Phase 3, Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Beverly Hills CA, Koreatown CA, Los Angeles CA,
Sponsor: Oncolytics Biotech

Sex: All

Age: 18+

Code: NCT07446322

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Beverly Hills CA, Los Angeles CA, Orange CA, Irvine CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis (gMG)
Location: Orange CA, San Francisco CA, Sacramento CA, Portland OR,
Sponsor: Cabaletta Bio

Sex: All

Age: 18 - 70

Code: NCT06359041

Phase 1, Phase 2, Recruiting

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa
Location: Northridge CA, Las Vegas NV, Phoenix AZ, Scottsdale AZ,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07170917

Phase 2, Recruiting

A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Beverly Hills CA, Irvine CA, Goodyear AZ, Denver CO,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07589634

Phase 2, Recruiting

PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: Beverly Hills CA, San Antonio TX, Margate FL
Sponsor: Pyrotech Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06244992

Phase 1, Phase 2, Recruiting

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

for
Non-small Cell Lung Cancer
Location: Beverly Hills CA, Bakersfield CA, Billings MT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06345729

Phase 3, Recruiting

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

for
Immune Thrombocytopenia
Location: Los Angeles CA, Clovis CA, Ogden UT, Portland OR,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07007962

Phase 3, Recruiting

Visible Abdominal Distension

for
Irritable Bowel Syndrome, Dyspepsia, Functional Bloating
Location: Los Angeles CA, Hamilton
Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Sex: All

Age: 18 - 70+

Code: NCT06369753

Recruiting

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-Resistant Prostate Cancer
Location: Los Angeles CA, Goodyear AZ, San Francisco CA,
Sponsor: Kyntra Bio

Sex: Male

Age: 18+

Code: NCT06842498

Phase 2, Recruiting

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

for
Radiographic Axial Spondyloarthritis
Location: Fullerton CA, Huntington Beach CA, Upland CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07133633

Phase 2, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Los Angeles CA, Santa Monica CA, Duarte CA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase 3, Recruiting

Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)

for
Internal Hemorrhoids, HAE
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 70+

Code: NCT07179601

Recruiting

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Los Angeles CA, Pasadena CA, Orange CA, La Jolla CA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07207811

Phase 3, Recruiting

A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease

for
Immunoglobulin G4 Related Disease
Location: Fontana CA, San Jose CA, Sacramento CA, Seattle WA,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07190196

Phase 3, Recruiting

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

for
Prostate Carcinoma, Recurrent Prostate Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Male

Age: 30 - 70+

Code: NCT07202247

Phase 2, Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles